SYNAPTIC PHARMACEUTICAL CORP (CIK: 0000884939) EDGAR, Information, Filings... CompaniesBIO.Com

SYNAPTIC PHARMACEUTICAL CORP

Mailing address
, , Delaware,
Phone
2012611331
State location
New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Filings
N/A

SYNAPTIC PHARMACEUTICAL CORP (CIK: 0000884939) is an American company incorporated in the state of New Jersey. Head office is located at 215 COLLEGE RD, PARAMUS, New Jersey, 07652. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. SYNAPTIC PHARMACEUTICAL CORP is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SYNAPTIC PHARMACEUTICAL CORP

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-04-023233 ( Act) Size: 17 KB	Feb-13-2004	005-45417 04599371
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001047469-03-008000 ( Act) Size: 14 KB	Mar-07-2003	333-71026 03595453
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001047469-03-007999 ( Act) Size: 12 KB	Mar-07-2003	333-05793 03595450
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000899140-03-000245 ( Act) Size: 15 KB	Mar-07-2003	005-45417 03595449
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001047469-03-007965 ( Act) Size: 6 KB	Mar-07-2003	000-27324 03595199
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001047469-03-007869 ( Act) Size: 18 KB	Mar-06-2003	005-45417 03594168
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950157-03-000126 ( Act) Size: 12 KB	Mar-06-2003	000-27324 03594072
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950157-03-000125 ( Act) Size: 10 KB	Mar-06-2003	005-45417 03594064
8-K	Document	Current report filing Acc-no: 0001047469-03-007846 ( Act) Size: 16 KB	Mar-06-2003	000-27324 03593908
8-K	Document	Current report filing Acc-no: 0001047469-03-007628 ( Act) Size: 17 KB	Mar-04-2003	000-27324 03591437
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0000950123-03-002079 ( Act) Size: 57 KB	Feb-27-2003	333-71026 03581714
8-K	Document	Current report filing Acc-no: 0001047469-03-004680 ( Act) Size: 17 KB	Feb-11-2003	000-27324 03549219
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000898430-03-000760 ( Act) Size: 82 KB	Feb-07-2003	005-45417 03545433
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950135-03-000627 ( Act) Size: 20 KB	Feb-04-2003	005-45417 03538287
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001047469-03-001169 ( Act) Size: 28 KB	Jan-13-2003	005-45417 03512443
DEFR14A	Document	Definitive revised proxy soliciting materials Acc-no: 0001047469-03-001081 ( Act) Size: 768 KB	Jan-10-2003	000-27324 03511244
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902219-03-000019 ( Act) Size: 11 KB	Jan-10-2003	005-45417 03510351
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001047469-03-000957 ( Act) Size: 14 KB	Jan-10-2003	000-27324 03509738
DEFM14A	Document	Definitive proxy statement relating to a merger,acquisition, or disposition Acc-no: 0001047469-03-000955 ( Act) Size: 756 KB	Jan-10-2003	000-27324 03509725
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001047469-02-007335 ( Act) Size: 90 KB	Dec-17-2002	005-45417 02860720

Recent 20 filings. View all SYNAPTIC PHARMACEUTICAL CORP filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

SYNAPTIC PHARMACEUTICAL CORP overview
SYNAPTIC PHARMACEUTICAL CORP job
SYNAPTIC PHARMACEUTICAL CORP stock
SYNAPTIC PHARMACEUTICAL CORP ownership
SYNAPTIC PHARMACEUTICAL CORP CEO
SYNAPTIC PHARMACEUTICAL CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.